Slusarewicz P, Xu Z, Seefeld K, Haas A, Wickner W T
Department of Biochemistry, Dartmouth Medical School, Hanover, NH 03755-3844, USA.
Proc Natl Acad Sci U S A. 1997 May 27;94(11):5582-7. doi: 10.1073/pnas.94.11.5582.
Saccharomyces cerevisiae vacuole inheritance requires two low molecular weight activities, LMA1 and LMA2. LMA1 is a heterodimer of thioredoxin and protease B inhibitor 2 (I2B). Here we show that the second low molecular weight activity (LMA2) is monomeric I2B. Though LMA2/I2B was initially identified as a protease B inhibitor, this protease inhibitor activity is not related to its ability to promote vacuole fusion: (i) Low Mr protease B inhibitors cannot substitute for LMA1 or LMA 2, (ii) LMA1 and LMA2 promote the fusion of vacuoles from a strain that has no protease B, (iii) low concentrations of LMA2 that fully inhibit protease B do not promote vacuole fusion, and (iv) LMA1, in which I2B is complexed with thioredoxin, is far more active than LMA2/I2B in promoting vacuole fusion and far less active in inhibiting protease B. These studies establish a new function for I2B.
酿酒酵母液泡遗传需要两种低分子量活性物质,即LMA1和LMA2。LMA1是硫氧还蛋白与蛋白酶B抑制剂2(I2B)的异源二聚体。在此我们表明,第二种低分子量活性物质(LMA2)是单体I2B。尽管LMA2/I2B最初被鉴定为蛋白酶B抑制剂,但这种蛋白酶抑制剂活性与其促进液泡融合的能力无关:(i)低分子量蛋白酶B抑制剂不能替代LMA1或LMA2,(ii)LMA1和LMA2促进来自无蛋白酶B菌株的液泡融合,(iii)完全抑制蛋白酶B的低浓度LMA2不能促进液泡融合,以及(iv)I2B与硫氧还蛋白复合的LMA1在促进液泡融合方面比LMA2/I2B活性高得多,而在抑制蛋白酶B方面活性低得多。这些研究确立了I2B的新功能。